Federal Audit Survival: How Proper IRB Documentation Saves Careers
By Alysia Adams, DNP, APRN, AGACNP-BC, CCRN, NE-BC
In many healthcare and research settings, IRB review is often treated as a step to complete before the real work begins.
But even after a study concludes, when data is collected, and results are implemented, there comes a moment that brings everything back into focus.
This critical juncture is the audit—the point when past decisions and documentation are revisited.
Audits are a routine part of research and compliance oversight. At the federal level, agencies such as the Office for Human Research Protections and the Food and Drug Administration conduct both for-cause and not-for-cause reviews. At the institutional level, audits may occur annually, periodically, or in response to specific triggers such as publications, grant activity, or internal quality reviews.
In addition to these external reviews, many organizations and platforms supporting research processes have adopted ongoing internal audit practices.
For example, RapidIRB conducts quarterly reviews and audits approximately 30% of studies to ensure continued alignment with federal criteria and documentation standards. Put simply, audits are not rare events; instead, they are an expected and recurring part of research and evaluation work.
When you receive notification—whether a request for documentation, a compliance review notice, or a follow-up tied to publication or report—what matters most is what happens next. At that point, the spotlight quickly shifts from the project’s outcomes to the underlying process.
When the Questions Start
Audit requests are rarely complicated but precise.
You may be asked to provide:
- The IRB determination for the project
- Documentation supporting the exempt or non-human subjects classification
- Consent materials, if applicable
- Protocols, tools, or data collection processes
- Evidence of how decisions were made and by whom
There is often an assumption that if the work is low-risk, these questions will be easy to answer. Sometimes they are.
But when documentation is incomplete or when determinations were made informally, those questions become harder to answer with confidence.
Where Risk Quietly Enters
One of the most common patterns seen during audit review is not intentional noncompliance; it is informal decision-making. A project is thoughtfully developed. A team determines whether it is a quality improvement or an exempt activity. The work moves forward with good intent and meaningful outcomes. What is often missing is not judgment but documentation.
Without a structured and recorded determination:
- There is no clear record of how the decision was made.
- No alignment with federal criteria is demonstrated.
- There is no external validation of the classification.
And in an audit, that absence matters. When using RapidIRB, you can use your dashboard to locate study documentation.
The Role of the Principal Investigator
A critical point that is sometimes overlooked is this: responsibility for compliance does not sit solely with an organization or an IRB.
It sits with the Principal Investigator (PI).
The PI is responsible for:
- Ensuring the project is appropriately classified
- Securing the correct level of review or determination
- Maintaining documentation throughout the lifecycle of the work
- Being able to produce that documentation when requested
Even with IRB or external services, the PI must demonstrate adherence to proper processes.
This is not about adding burden. It is about maintaining ownership of the work.
The Value of a Clear, Structured Process
In environments where IRB infrastructure is readily available, this process is often embedded into the workflow. In other settings, clinical operations, innovation teams, and independent projects, there is an opportunity to bring that same level of clarity and structure into the process.
Having a consistent approach to:
- Determining project classification
- Applying federal criteria
- Generating formal documentation
creates a level of confidence that carries through the entire project lifecycle.
Solutions like RapidIRB are designed to support this process by offering structured, algorithm-driven determinations and immediate documentation that aligns with federal standards. This allows professionals to move forward with clarity, knowing that the foundation of their work is documented and defensible. For more on how quickly this process can move, see How Fast Can I Get an IRB Determination Online? To learn more about RapidIRB’s approach to compliance-first design, visit our About page.
🔍 Federal Audit Readiness Checklist
Before moving forward with your work, ask yourself:
☐ I have clearly determined whether this is research, QI, or non-human subjects work
☐ I have documented that determination in a structured, formal way
☐ My determination aligns with federal definitions and criteria
☐ I have official documentation supporting exempt or non-human subjects status (if applicable)
☐ My consent process (if applicable) is clearly defined and documented
☐ All study materials and decisions are organized and accessible
☐ My documentation would be clear and defensible to an external reviewer
☐ I could produce all required documentation immediately if audited
☐ I have documented that determination in a structured, formal way
☐ My determination aligns with federal definitions and criteria
☐ I have official documentation supporting exempt or non-human subjects status (if applicable)
☐ My consent process (if applicable) is clearly defined and documented
☐ All study materials and decisions are organized and accessible
☐ My documentation would be clear and defensible to an external reviewer
☐ I could produce all required documentation immediately if audited
References
- Office for Human Research Protections. (2018). Federal policy for the protection of human subjects (‘Common Rule’). U.S. Department of Health and Human Services. https://www.hhs.gov/ohrp
- Office for Human Research Protections. (n.d.). Compliance oversight procedures. U.S. Department of Health and Human Services. https://www.hhs.gov/ohrp/compliance
- Food and Drug Administration. (2023). Bioresearch monitoring program (BIMO). U.S. Department of Health and Human Services. https://www.fda.gov
- Office of Research Integrity. (2007). Introduction to the responsible conduct of research. U.S. Department of Health and Human Services.
- Resnik, D. B. (2018). The ethics of research with human subjects. Springer.
- Wager, E., & Kleinert, S. (2011). Responsible research publication: International standards for authors.
Ready to Accelerate Your Research?
Join investigators worldwide who trust Rapid IRB for instantaneous, valid determinations. Advance innovation without unnecessary delays while upholding ethical standards.
What Our Clients Say
Trusted by researchers, healthcare leaders, and institutions worldwide
As a researcher and healthcare leader, I value efficiency, clarity, and professionalism. RapidIRB delivers on all three. The platform is intuitive, the support team is responsive, and the process is streamlined…
Reneè Roberts-Turner, DHA, MSN, RN, NE-BC, CPHQ
Owner and Principal, Renee Roberts-Turner, LLC
RapidIRB is a game-changer for academic researchers like myself who often face long delays and opaque processes with traditional IRBs. I was impressed by how quickly I received a determination…
Dr. Michael Tran, PhD
Academic Researcher
As the Director of Clinical Innovation for a multi-site healthcare system, I was looking for a solution that would support fast, compliant IRB reviews without adding extra layers of complexity…
Laura Kim, MPH
Director of Clinical Innovation
Powerful Tools for Research Compliance
Our comprehensive suite of tools helps you navigate the complex landscape of research ethics and regulatory compliance for low-risk studies.
QIPR Tool
Determine if your project qualifies as Quality Improvement
Get an instant determination for your Quality Improvement and Practice-based Research projects with our expert-designed assessment tool.
Exempt Determination Tool
Check if your research qualifies for exempt status
Receive an instantaneous and valid exempt determination under federal regulations for low-risk research studies.